81 – 90 of 151
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The strategic biomarker roadmap for the validation of Alzheimer’s diagnostic biomarkers : methodological update
- Contribution to journal › Article
-
Mark
2020 update on the clinical validity of cerebrospinal fluid amyloid, tau, and phospho-tau as biomarkers for Alzheimer’s disease in the context of a structured 5-phase development framework
Leuzy, A. LU ; Ashton, N. J. ; Mattsson-Carlgren, N. LU
; Dodich, A.
; Boccardi, M.
; Corre, J.
; Drzezga, A.
; Nordberg, A.
; Ossenkoppele, R.
LU
and Zetterberg, H.
LU
, et al.
(2021)
In European Journal of Nuclear Medicine and Molecular Imaging
48(7).
p.2121-2139
- Contribution to journal › Scientific review
-
Mark
Comparing ATN-T designation by tau PET visual reads, tau PET quantification, and CSF PTau181 across three cohorts
Provost, Karine ; Iaccarino, Leonardo ; Soleimani-Meigooni, David N. ; Baker, Suzanne ; Edwards, Lauren ; Eichenlaub, Udo ; Hansson, Oskar LU
; Jagust, William
; Janabi, Mustafa
and La Joie, Renaud
, et al.
(2021)
In European Journal of Nuclear Medicine and Molecular Imaging
48(7).
p.2259-2271
- Contribution to journal › Article
-
Mark
Animal Models of Metabolic Disorders in the Study of Neurodegenerative Diseases : An Overview
de Bem, Andreza Fabro ; Krolow, Rachel ; Farias, Hémelin Resende ; de Rezende, Victória Linden ; Gelain, Daniel Pens ; Moreira, José Cláudio Fonseca ; Duarte, João Miguel das Neves LU
and de Oliveira, Jade
(2021)
In Frontiers in Neuroscience
14.
- Contribution to journal › Scientific review
-
Mark
Clinical validity of increased cortical uptake of [18F]flortaucipir on PET as a biomarker for Alzheimer’s disease in the context of a structured 5-phase biomarker development framework
Wolters, E. E. ; Dodich, A. ; Boccardi, M. ; Corre, J. ; Drzezga, A. ; Hansson, O. LU
; Nordberg, A.
; Frisoni, G. B.
; Garibotto, V.
and Ossenkoppele, R.
LU
(2021)
In European Journal of Nuclear Medicine and Molecular Imaging
48(7).
p.2097-2109
- Contribution to journal › Scientific review
-
Mark
Neuroligin-1 in brain and CSF of neurodegenerative disorders : investigation for synaptic biomarkers
Camporesi, Elena ; Lashley, Tammaryn ; Gobom, Johan ; Lantero-Rodriguez, Juan ; Hansson, Oskar LU
; Zetterberg, Henrik
LU
; Blennow, Kaj
LU
and Becker, Bruno
(2021)
In Acta Neuropathologica Communications
9(1).
- Contribution to journal › Article
-
Mark
Effect of Shortening the Scan Duration on Quantitative Accuracy of [18F]Flortaucipir Studies
- Contribution to journal › Article
-
Mark
Head-to-head comparison of amplified plasmonic exosome Aβ42 platform and single-molecule array immunoassay in a memory clinic cohort
- Contribution to journal › Article
-
Mark
Nano-Infrared Imaging of Primary Neurons
O. Freitas, Raul ; Cernescu, Adrian ; Engdahl, Anders LU ; Paulus, Agnes LU ; E. Levandoski, João ; Martinsson, Isak LU ; Hebisch, Elke LU ; Sandt, Christophe ; Keppler Gouras, Gunnar LU
and Prinz, Christelle
LU
, et al.
(2021)
In Cells
10(10).
p.1-15
- Contribution to journal › Article
-
Mark
Ex vivo MRI atlas of the human medial temporal lobe : characterizing neurodegeneration due to tau pathology
Ravikumar, Sadhana ; Wisse, Laura E.M. LU
; Lim, Sydney
; Ittyerah, Ranjit
; Xie, Long
; Bedard, Madigan L.
; Das, Sandhitsu R.
; Lee, Edward B.
; Tisdall, M. Dylan
and Prabhakaran, Karthik
, et al.
(2021)
In Acta Neuropathologica Communications
9(1).
- Contribution to journal › Article